Global pharma major Lupin has announced the appointment of Dr Ranjana Pathak as Chief Quality Officer, succeeding Johnny Mikell who will be retiring from the services of the company.
With over three decades of industry experience, Dr Ranjana brings a wealth of expertise and leadership and will oversee all aspects of quality and regulatory compliance for Lupin’s global operations.
Dr Ranjana’s career includes serving as the Global Head for Quality and Pharmacovigilance at Dr. Reddy’s. Prior to this, she served as the President & Global Head of Quality, Medical Affairs and Pharmacovigilance at Cipla and has also held Global Quality and Compliance leadership positions at Watson/Actavis and Endo Pharmaceuticals in the US. Dr Ranjana has strong experience across generic and brand medicines across dosage platforms including injectables, inhalation products and biologics.
Vinita Gupta, CEO and Nilesh Gupta, MD, Lupin said, “Her extensive global experience and proven track record in building and sustaining a strong culture of quality and compliance align with Lupin’s commitment to be best-in-class in delivering quality products to the communities we serve.”
